BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3314635)

  • 1. Monitoring of renal allografts by Doppler ultrasound.
    Ubhi CS; Irving HC; Norwood HM; Guillou PJ; Giles GR
    Ann R Coll Surg Engl; 1987 Sep; 69(5):229-32. PubMed ID: 3314635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Duplex sonographic findings following kidney transplantation-- possible value in the diagnosis of graft rejection].
    Gückel C; Lorenz R; Hesse U
    Digitale Bilddiagn; 1988 Jun; 8(2):97-101. PubMed ID: 3042260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of pulsed Doppler for the follow-up of the transplanted kidney in the first 3 months of transplantation].
    Attal M; Bitker MO; Bousquet JC; Luciani J; Maidenberg M; Bellin F; Curet P; Chatelain C; Grellet J
    Ann Urol (Paris); 1990; 24(3):224-31. PubMed ID: 2163233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
    Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
    Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity.
    Stojanovic T; Gröne HJ; Gieseler RK; Klanke B; Schlemminger R; Tsikas D; Gröne EF
    Lab Invest; 1996 Feb; 74(2):496-512. PubMed ID: 8780167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
    Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler spectrum analysis in the differential diagnosis of renal transplant dysfunction.
    Merkus JW; van Asten WN; Hoitsma AJ; van't Hof MA; Koene RA; Skotnicki SH
    Clin Transplant; 1996 Oct; 10(5):420-8. PubMed ID: 8930455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinction between acute renal transplant rejection and cyclosporine nephrotoxicity: value of duplex sonography.
    Buckley AR; Cooperberg PL; Reeve CE; Magil AB
    AJR Am J Roentgenol; 1987 Sep; 149(3):521-5. PubMed ID: 3303879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current topics of the rejection pathology in human renal allografts].
    Morozumi K; Fukuda M; Takeda A
    Hinyokika Kiyo; 1998 May; 44(5):353-7. PubMed ID: 9656109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft recipient. The differentiation of drug nephrotoxicity from rejection by phenotyping of cellular infiltrates.
    Kolbeck PC; Scheinman JI; Sanfilippo F
    Arch Pathol Lab Med; 1986 May; 110(5):389-93. PubMed ID: 3516116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler ultrasound in the diagnosis of renal allograft rejection and in monitoring the effect of treatment.
    Rasmussen K; Pedersen E
    Scand J Clin Lab Invest; 1990 Feb; 50(1):57-61. PubMed ID: 2180059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage of Cyclosporin A in children with renal transplants.
    Hoyer PF; Offner G; Wonigeit K; Brodehl J; Pichlmayr R
    Clin Nephrol; 1984 Aug; 22(2):68-71. PubMed ID: 6383673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplex Doppler evaluation of renal allograft dysfunction.
    Marchal G; Rigauts H; Van Damme B; Vanrenterghem Y; Waer M; Verbrugge H; Baert A; Michielsen P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1893-4. PubMed ID: 2652615
    [No Abstract]   [Full Text] [Related]  

  • 20. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.